膝关节翻修术中结构性异体植骨的应用及手术技巧

Application and surgical techniques of structural allograft in treatment of patients with serious bone defects

  • 摘要: 目的 比较膝关节翻修术中是否使用结构性异体骨移植的临床效果,并探讨植骨手术技巧及相关问题。 方法 回顾性分析2010年7月-2013年6月我院收治的34例膝关节置换术后由于各种原因在我院骨科行膝关节翻修术的病例,平均年龄64.6(51 ~ 76)岁,平均随访28.5(14 ~ 46)个月。根据术中是否使用结构性异体骨移植分为治疗组和对照组。治疗组使用结构性异体植骨处理骨缺损;对照组使用颗粒打压植骨和骨水泥填充等常规方法处理。通过KSS评分评估患者症状改善和关节功能恢复情况,通过X线检查评估术后假体在位情况和植骨愈合情况。 结果 两组各有1例失访,其他患者假体在位良好。治疗组X线片提示植骨均愈合。两组患者随访时的KSS评分较术前均有显著提高。治疗组术前的骨缺损情况较对照组严重,KSS评分低于对照组(38.19±18.71vs 52.39±9.79) (t=2.891,P=0.008),但随访时两组KSS临床评分(85.19±10.23vs 90.39±5.71) (t=1.859,P=0.072)、疼痛评分(45.00±5.16vs 43.33±5.69) (t=0.859,P=0.377)、功能评分(63.13±19.12vs 72.78±16.74) (t=1.557,P=0.130)差异均无统计学意义。 结论 使用结构性异体骨移植修复膝关节翻修中的大块骨缺损可取得较好效果,与其他骨缺损的处理方法相比,临床效果无明显差异。

     

    Abstract: Objective To compare the effectiveness of whether or not using structural allograft in treatment of patients with serious bone defects in revision total knee arthroplasty (RTKA). Methods Thirty-four patients who underwent RTKA in our department from July 2010 to June 2013 were selected with an average age of 64.6 years (range 51-76) and follow-up period of 28.5 month(range 14-46). They were divided into treatment group and control group according to the usage of allograft or not. Patients in treatment group underwent structural allograft during the operation. In control group, morselized bone graft and bone cement were used to repair bone defects. Knee Society Score were used to evaluate the improvement of symptoms and joint function. And X-ray films were used to evaluate prosthesis location and bone graft healing. Results Two cases were lost following up in two groups, one in each group. In the treatment group, all the allograft were healed. Prostheses were in normal location in all patients. The mean KSS score during the follow up was higher than the preoperative score in both groups (treatment group t=8.839, P< 0.05; control group t=11.824, P< 0.05). Before operation, the KSS clinic score in treatment group was lower than that in control group [(38.19±18.71)vs (52.39±9.79), t=2.891, P=0.008]. But the KSS clinic score [(85.19±10.23)vs (90.39±5.71), t=1.859, P=0.072], pain score[(45.00±5.16)vs (43.33±5.69), t=0.859, P=0.377] and function score [(63.13±19.12)vs (72.78±16.74), t=1.557, P=0.130] during the follow up were of no significant difference between two groups. Conclusion Structural allograft in treatment of patients with serious bone defects in RTKA shows good efficacy. There is no significantly clinical difference compared with other methods.

     

/

返回文章
返回